Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendations.
Angelo SangiovanniMichela TrioloMassimo IavaroneLaura V ForzenigoAntonio NicoliniGiorgio RossiVincenzo la MuraMassimo ColomboPietro LamperticoPublished in: Liver international : official journal of the International Association for the Study of the Liver (2018)
HCC multimodality treatment including other than first-line therapy is common in clinical practice and impact on the achievement of complete response. Personalized treatment was able to provide survival benefits to patients whose profile is not accounted for by international recommendations, which need to be amended.